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Today, one of the most urgent problems of public health is the
development of effective methods to block the carcinogenesis
sequential events. Chemical carcinogenesis has been recognized to
generally have three stages: initiation, promotion and progression
(Hennings et al, 1983; Boutwell, 1989; Pitot and Dragan, 1991).
Because a cure for cancer has not been established, cancer chemo-
prevention from edible plants may become a means to reduce
cancer incidence.
Chemical chemoprevention is a concept defined as the preven-
tion of cancer by the administration of natural or synthetic pure
chemicals, or by daily foods enriched with cancer preventive
components (Wattenberg, 1985; Greenwald et al, 1990; Weinstein,
1991; Morse and Stoner, 1993). Primary cancer prevention has
two aspects in its methodology: (1) exclusion or avoidance of the
environment carcinogens or other chemical factors closely relating
to carcinogenesis such as tumour promoters; and (2) the adminis-
tration of inhibitory or suppressive agents against carcinogenesis
(Murakami et al, 1994). Because the continuous exposure to envi-
ronmental and food carcinogens is inevitable in daily life, direct
inhibition or suppression at the tumour-promoting stage could be
an achievable strategy. Particularly, phytochemicals from edible
plants would have an advantage in their clinical application on
account of low toxicity. In fact, a great number of epidemiological
studies of the relationship between food and cancer, together with
research in experimental animal models, have demonstrated that
daily ingestion of some vegetables and fruits could undoubtedly
contribute to cancer prevention (Doll, 1992; Watternberg, 1992;
Ziegler et al, 1992; Rogers et al, 1993).
Several compounds have been discovered with inhibitory
effects on the tumour-promoting stage, and interestingly many of
them were derived from plants. Koshimizu et al (1988) conducted
screening tests of the methanol extracts from 121 species of
Japanese vegetables and fruits for inhibitory activity toward
Epstein–Barr virus early antigen (EBV-EA) activation induced by
a 12-O-tetradecanoylphorbol-13-acetate (TPA) analogue 12-O-
hexadecanoylphorbol-13-acetate (HPA). As a result, 26% of the
total showed significant inhibitory activity (>30% at 200 mg ml–1).
These results show that anti-tumour promoters occur in a wide
variety of plants.
The Zingiberaceae is a well-known plant family in Southeast
Asia and numerous of its species are being used in traditional
medicine, which is found to be quite effective in the treatment of
several diseases. In Malaysia, various ginger rhizobia are widely
used in the traditional treatment of ailments such as stomach
problems, nausea, vomiting, epilepsy, sore throat, cough, bruises,
wounds, childbirth, eyewash, sore eyes, liver complaints, rheuma-
tism, muscular pains, ringworm, asthma, fever, malignancies,
swelling and several other disorders (Burkill, 1966).
Curcuma domestica, Kaempferia galanga and Languas galanga
from the Zingiberaceae family have been reported to demonstrate
anti-tumour promoter activity (Koshimizu et al, 1988; Nishino
et al, 1990). Several other ginger species are used in Malaysian
traditional medicine, but their anti-tumour promoter activity has
not been previously investigated. Thus, further examination of the
Zingiberaceae species on their anti-tumour-promoting activity was
worthwhile undertaking. The primary objective of this study was
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to screen several species of the Zingiberaceae family most
frequently used in local traditional medication for the presence of
anti-tumour promoter activity. The short-term assay of inhibition
of TPA-induced EBV-EA in Raji cells was used to identify poten-
tial anti-tumour promoter activity in seven Malaysian ginger
rhizobia.
Human lymphoblastoid Raji, a non-producer cell line which
harbours multiple copies of EBV genomes (Ernberg and Klein,
1979), can be activated by tumour promoters such as TPA to
express EBV-EA (Kawanishi and Ito, 1982). Zur Hausen et al
(1978, 1979) demonstrated that phorbol esters which possessed
tumour-promoting activity could induce viral cycle in latently
infected cells carrying EBV, and Ito et al (1981a) noted that low
concentration of n-butyrate increased the effects of tumour
promoters synergistically. It is noteworthy that such EBV-acti-
vating principles can be considered to possess tumour-promoting
capacity (Ito et al, 1981b). However, extracts of certain plant
species were found to inhibit the TPA-induced EBV-EA activa-
tion. Thus, this assay system of inhibition of EBV-EA activation
by TPA in indicator Raji cells is regularly used as an early method
of detecting anti-tumour-promoting principles in natural products.
Inhibitory potentials against tumour promoter-induced EBV acti-
vation has been reported to be well correlated with those in some
animal models (Murakami et al, 1996). Ursolic acid and mokko
lactone, isolated from green perrilla and edible burdok extracts
respectively, were found to inhibit EBV-EA activation induced by
HPA (Koshimizu et al, 1988), and proven to have anti-tumour-
promoting activity in ICR mice skin (Koshimizu and Ohigashi,
1991). Several other active components from common food that
inhibited the TPA-induced EBV-EA activation (Ohigashi et al, 1986)
were also shown to inhibit skin tumour formation by TPA in 7,12-
dimethylbenz[a]anthracene-initiated mice (Tokuda et al, 1986).
Some of the naturally occurring anti-tumour promoters identified
in edible Thai plants by the inhibitory test of EBV-EA
activation, induced by 40 ng ml–1 HPA (Murakami et al, 1995a),
have further been proven to possess anti-tumour-promoting activity
in vivo (Murakami et al, 1995b). Ohigashi et al (1992) screened
marine algae, which is claimed to reduce cancer risk in Japan, for
EBV-EA activation inhibitory activity and the dichloromethane of
Undaria pinnatifida that showed strong inhibitory activity (>70% at
4 mg ml–1) was also found to completely suppress tumour formation
on mouse skin induced by DMBA and TPA. The acetone extract of
Scutellaria baicalensis that showed significant inhibitory effects on
EBV-EA activation in vitro was fractionated with ethyl acetate and
two flavones, 5,7,2¢-trihydroxyflavone and 5,7,2¢,3¢-tetrahydroxy-
flavone were found to exhibit strong inhibitory effect on mouse skin
tumour promotion in an in vivo two-stage carcinogenesis test
(Konoshima et al, 1992).
The above findings show that the EBV genome carrying human
lymphoblastoid cells (Raji), activated by tumour promoters, has been
used widely as a screening assay for the early detection of anti-
tumour promoters. In our search for natural inhibitors against tumour
promotion, we screened eleven ginger rhizomes commonly found as
ingredients in the Malaysian traditional medicine using the inhibition
of TPA-induced EBV-EA activation assay.
MATERIALS AND METHODS
Plant material
Rhizomes of eleven species from the Zingiberaceae family,
Curcuma aeruginosa (temu hitam), Curcuma domestica
(turmeric/kunyit),  Curcuma mangga (temu pauh), Curcuma xanth-
orrhiza (temu lawak), Gastrochilus panduratum (temu kunci),
Kaempferia galanga (chekur),  Languas galanga (lengkuas),
Zingiber cassumunar (bonglai), Zingiber officinale (ginger/halia),
Zingiber officinale (red variety) (halia bara) and Zingiber
zerumbet (lempoyang), were collected from the University of
Malaya botanical garden, Rimba Ilmu.
Preparation of crude extracts
The Zingiberaceae rhizomes were extracted by the method of Ito
et al (1983). Five grams of dried, ground rhizome was extracted
using petroleum ether, chloroform and ethanol solvents succes-
sively. The powdered rhizome was soaked for 3 days in 20 ml of
solvent. On day 3, the extract was removed from the plant debris
and subjected to evaporation. The dry crude extract obtained was
dissolved in DMSO (Sigma) to provide a stock solution of
20 mg ml–1 and stored at –20°C. The plant debris were dried and
resoaked with the following solvent.
EBV early antigen (EA) induction in Raji cells
The technique used was as described previously (Ito et al, 1981a;
Yadav et al, 1989). Raji cells were obtained from the National
Cancer Institute, Bethesda, MD, USA (courtesy of Dr DV
Ablashi). The culture medium consisted of RPMI-1640 medium
supplemented with L-glutamine (0.2 g l–1), inactivated fetal
calf serum (10%), streptomycin (100 mg ml–1) and penicillin
(100 IU ml–1). Rapidly growing human lymphoblastoid Raji cells
in log phase at a density of 1´106 cells ml–1 were incubated with
plant extracts at concentrations ranging from 20 to 640 mg ml–1 in
the presence of 20 ng ml–1 TPA (Sigma) and 4 mmol ml–1 sodium
n-butyrate (Sigma). The cells were incubated for 72 h in a humidi-
fied incubator at 37°C with 5% carbon dioxide in air, without
change of media. Previous studies showed that optimum EA
activity was obtained after 72 h of incubation (Yadav et al, 1989).
The positive controls consisted of untreated culture media and Raji
cells treated with 4 mmol ml–1 sodium n-butyrate. The negative
control consisted of Raji cells treated with optimal concentration,
20 ng ml–1 of TPA and 4 mmol ml–1 sodium n-butyrate. The assay
was repeated once to obtain consistent results.
Indirect immunofluorescence assay (IFA)
To observe the EBV-EA expression in the treated and fixed cells, a
modification of the indirect IFA was used (Henle and Henle, 1966;
Henle et al, 1971). EBV EA-positive serum, obtained from
nasopharyngeal carcinoma (NPC) patients, with titre values of
1:640 and 1:1280 were used to detect the presence of EBV-EA.
Twenty microlitres of the serum, at a dilution of 1:20, was
dispensed into each well of the multitest slide containing acetone-
fixed Raji cells. The slides were then incubated in a humidity
chamber at 37°C for 45 min. At the end of the incubation period,
the slides were washed with phosphate-buffered saline (PBS) and
20 ml of fluorescein thiocynate-conjugated (FITC) IgG, at a dilu-
tion of 1:20, was added to each well. The slides were reincubated
and washed as above and air dried.
Detection of EBV activation inhibitory activity
The fluorescence of the cells were observed using a UV micro-
scope (Olympus, Japan). The control cells, both positive and
negative, were routinely incorporated in each assay.112 S Vimala et al
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Treatment with increasing concentrations of plant extracts
decreased the number of fluorescent cells. Hence, the first well
which showed no fluorescent cells was taken as the concentration
and titre for complete EBV activation inhibitory activity
[inhibitory effect (IE): 100%].
EBV activation was measured by detection of EA. The ratio of
EA-induced cells was compared with that of a control experiment
only with sodium n-butyrate and TPA, in which the ratio of EA-
induced cells was ordinarily around 50%. The control was consid-
ered as 100% tumour promotion and 0% inhibition.
Anti-tumour promoter standard
Ascorbic acid (1000 mM; Sigma), a known anti-tumour promoter,
was used as a standard for method validation. It showed 50%
inhibition against TPA-induced EBV-EA activation in Raji cells
compared with negative control and 0% cytotoxicity relative to
controls.
Cytotoxicity assay
Rapidly growing human lymphoblastoid Raji cells were incubated
as mentioned above. On day 3, the cells were spun down at
1000 r.p.m for 5 min and 0.1% of Trypan Blue was added to the
cell suspension. Cell enumeration was carried out using a haemo-
cytometer.
Detection of the EA protein suppression (Western blot)
The EBV-EA protein suppression was detected by the Western blot
technique (Towbin et al, 1979; Burnette, 1981). Gel electro-
phoresis was carried out according to the method of Laemmli
(1970). Bio-Rad prestained standards of both low and high range
were used as markers. The protein bands were transferred to a
piece of Immobilon PVDF transfer membrane in a semidry
transfer cell (Bio-Rad, USA) using a constant current of 0.5 mA
for a period of 1 h. Then the transfer membrane was removed from
the sandwich and incubated in 0.1 ml of blocking solution per cm2
of the membrane for 1–2 h at room temperature with gentle agita-
tion. The blocking solution consisted of 5 g of non-fat milk
(Oxoid, UK) and 20 ml of Tween-20 (Merck, Germany) in 100 ml
of PBS. The membrane was then incubated overnight with NPC
serum diluted in the blocking solution (1:200) at 4°C with gentle
agitation. The following morning, the membrane was washed three
times and incubated in 0.5 mg ml–1 of enzyme-coupled secondary
reagent, affinity purified goat anti-human (H&L) IgG horseradish
peroxidase conjugate (Bio-Rad, USA) for 1 h at room temperature
with gentle agitation. The membrane was then immersed in the
colour development solution (Bio-Rad) containing chromogenic
substrate with enzyme-coupled antibody and incubated at room
temperature with gentle agitation for about 2–3 min till the protein
bands were clearly visible.
RESULTS
Eleven ginger rhizomes were screened for anti-tumour promoter
activity using the indirect IFA and Western blot technique, and the
results obtained from these two techniques were compatible.
The indirect IFA detected the inhibition of TPA-induced EBV-
EA-D (diffused EA complex) in Raji cells. The positive controls,
which consisted of untreated Raji cells and Raji cells treated with 4
mmol ml–1 sodium n-butyrate, demonstrated non-fluorescing cells,
i.e. no expression of the EBV-EA. The negative control that
consisted of Raji cells treated with the combination of 20 ng ml–1
TPA and 4 mmol ml–1 sodium n-butyrate showed 100% expression
of the EBV-EA through fluorescing cells that were detected by the
indirect IFA. As shown in Table 1, seven ginger rhizomes were
found to express EBV activation inhibitory activity when tested at
Table 1 Inhibition (%) of TPA-induced EBV-EA activation (IFA)
Plant Extract
(vernacular name)
Extract concentration (mg ml–1)
20 40 80 160 320 640
Curcuma domestica Petroleum ether 100 100 100 ct ct ct
(kunyit) Chloroform 100 100 100 100 100 100
Ethanol 100 100 100 100 100 100
Curcuma xanthorrhiza Chloroform 0 100 ct ct ct ct
(temu lawak) Ethanol 0 0 66 100 ct ct
Kaempferia galanga Ethanol 0 0 0 0 80 90
(chekur)
Zingiber cassumunar Petroleum ether 100 100 100 ct ct ct
(bonglai) Chloroform 100 100 100 100 100 100
Ethanol 0 80 100 100 100 100
Zingiber officinale Petroleum ether 0 0 100 100 ct ct
(halia) Chloroform 0 100 100 100 ct ct
Ethanol 0 0 81.7 100 ct ct
Zingiber officinale Petroleum ether 0 0 100 ct ct ct
(red variety) Chloroform 0 100 100 100 ct ct
(halia bara) Ethanol 0 0 0 88 96 100
Zingiber zerumbet Chloroform 100 100 100 100 ct ct
(lempoyang) Ethanol 0 0 70 96.7 100 ct
100%, complete inhibition; 99–1%, partial inhibition; 0%, no inhibition; ct, cytotoxic. Data, expressed as percentage of EA
inhibition, are mean values of duplicate experiments (s.d.<5%).Anti-tumour promoter activity in ginger 113
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concentrations of 20–640 mg ml–1 cell culture medium. They were
C. domestica, C. xanthorrhiza, Z.  officinale,  Z.  officinale (red
variety), Z. cassumunar, Z. zerumbet and K. galanga.
Similar results were obtained with the Western blot technique that
detected the suppression of TPA-induced EBV-EA-D and EA-R
(restricted EA complex), as shown in Table 2. The positive controls
did not express any EA protein bands whereas the negative control
was found to express the EA-D (47–56 kDa) and EA-R (85 kDa)
components. An example of EA protein suppression by the petro-
leum ether extract of Z. officinale at concentrations 80–640 mg ml–1
is shown in Figure 1.
A cytotoxicity assay was carried out to determine the toxicity of
the ginger extracts in Raji cells. The controls that consisted of
untreated Raji cells, Raji cells treated with 4 mmol ml–1 sodium n-
butyrate and Raji cells treated with the combination of 20 ng ml–1
TPA and 4 mmol ml–1 sodium n-butyrate showed no signs of
cytotoxicity. These controls had dividing Raji cells at a density of
1´106 cells ml–1. The percentage of killing shown in Table 3 is
relative to these controls in which treatment with ginger extracts
that caused cell death relatively more than controls were consid-
ered cytotoxic.
C. domestica, Z. cassumunar and Z. zerumbet showed strong
inhibitory activity against TPA-induced EBV-EA activation. At
all concentrations tested (20–640 mg ml–1), the chloroform and
ethanol extracts of C.  domestica and the chloroform extract
of Z.  cassumunar demonstrated complete inhibitory activity
(IE = 100%). The chloroform extract of Z.  zerumbet showed
complete inhibitory activity (IE = 100%) at concentrations 20–
160 mg ml–1. The petroleum ether extracts of C. domestica and
Z. cassumunar showed complete inhibitory activity (IE = 100%)
at concentrations 20–80 mgm l –1. The ethanol extracts of
Z.  cassumunar and  Z.  zerumbet demonstrated 70–100% IE at
concentrations 40–640 mg ml–1. At these extract concentrations
that inhibited EBV activation significantly, no cytotoxicity (CT)
was observed in Raji cells (CT = 0%). However, the petroleum
ether extract of Z. zerumbet was found to be toxic to Raji cells at
all concentrations used.
Z.  officinale and its red variety demonstrated EBV-EA
inhibitory activity at higher concentrations. Complete inhibition
(IE = 100%) was observed at 40–160 mg ml–1 with treatment of
Table 2 EBV-EA protein suppression in Raji cells detected by Western blot
Plant Extract
(vernacular name)
Extract concentration (mg ml–1)
20 40 80 160 320 640
Curcuma domestica Petroleum ether + + + ct ct ct
(kunyit) Chloroform + + + + + +
Ethanol + + + + + +
Curcuma xanthorrhiza Chloroform – + ct ct ct ct
(temu lawak) Ethanol – – ± +c t c t
Kaempferia galanga Ethanol – – – – ±±
(chekur)
Zingiber cassumunar Petroleum ether + + + ct ct ct
(bonglai) Chloroform + + + + + +
Ethanol – ± ++ + +
Zingiber officinale Petroleum ether – – + + ct ct
(halia) Chloroform – + + + ct ct
Ethanol – – ± +c t c t
Zingiber officinale Petroleum ether – – + ct ct ct
(red variety) Chloroform – + + + ct ct
(halia bara) Ethanol – – – ±± +
Zingiber zerumbet Chloroform + + + + ct ct
(lempoyang) Ethanol – – ±± +c t
+, Complete protein suppression; ±, partial protein suppression; –, no protein suppression; ct, cytotoxic. Observational data
were derived from duplicate experiments.
1 1 1 0 987654321
85 kDa
50 kDa
Figure 1 Western Blot with petroleum ether extract of Z. officinale rhizome.
A 12% SDS polyacrylamide gel electrophoresis (PAGE) run, transferred to
Immobilon PVDF in the semidry Trans-Blot cell. Blot was treated with NPC
(EA+) serum as primary antibody and goat anti-human IgG HRP conjugate
as secondary antibody. The colour reaction was carried out using HRP
conjugate substrate. Loading pattern: lane 1, prestained SDS-PAGE
standard, low range; lane 2, prestained SDS-PAGE standard, high range;
lane 3, untreated Raji cells, positive control; lane 4, Raji + 4 mmol ml–1
sodium n-butyrate, positive control; lane 5, Raji + n-b + 20 ng ml–1 TPA,
negative control; lane 6, Raji + n-b + TPA + 20 mg ml–1 plant extract; lane 7,
Raji + n-b + TPA + 40 mg ml–1 plant extract; lane 8, Raji + n-b + TPA +
80 mg ml–1 plant extract; lane 9, Raji + n-b + TPA + 160 mg ml–1 plant extract;
lane 10, Raji + n-b + TPA + 320 mg ml–1 plant extract; lane 11, Raji + n-b +
TPA + 640 mg ml–1 plant extract. The blot shows the EBV EA-D (47–56 kDa)
and EA-R (85 kDa) protein bands, which were identified in lanes 5, 6 and 7
and were suppressed in lanes 8–11114 S Vimala et al
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their chloroform extracts and 80–160 mg ml–1 with petroleum ether
extracts. At 20 mg ml–1, no inhibitory activity was observed (IE =
0%), and at concentrations above 160 mg ml–1 cytotoxicity was
observed (CT = 90–100%). C. xanthorrhiza demonstrated 100%
IE at 40 mg ml–1 and 160 mg ml–1 with treatment of the chloroform
and ethanol extracts, respectively, however at higher concentra-
tions cytotoxicity was observed (CT = 90–100%). At 20 mg ml–1,
no inhibitory effect was observed with these extracts (IE = 0%).
The petroleum ether extract of C. xanthorrhiza did not inhibit EA
activation at 20 mg ml–1 and was toxic to Raji cells at all other
concentrations.
The ethanol extract of K. galanga demonstrated partial inhibi-
tion (IE = 80–90%) at concentrations of 320–640 mgm l –1. At
lower concentrations of 20–80 mg ml–1, no inhibition was observed
(IE = 0%) with all three extracts. At concentrations of 160–
640 mgm l –1, cytotoxicity was observed with the treatment of
petroleum ether and chloroform extracts.
Four other Zingiberaceae species, C. aeruginosa, C. mangga, G.
panduratum and L. galanga, caused cell death (CT = 60–100%)
because of toxicity at all concentrations tested, thus the EBV-EA
inhibitory activity could not be determined.
DISCUSSION
In the present study, 7 out of 11 ginger rhizomes tested were found
to possess EBV-EA inhibitory activity with no cytotoxicity effect
in Raji cells. They are C. domestica, C. xanthorrhiza, Kaempferia
galanga,  Zingiber cassumunar, Z.  officinale,  Z.  officinale (red
variety) and Z. zerumbet.
C. domestica or turmeric, which showed strong EA inhibitory
activity, has had an extremely long use among the Malaysians
(Burkill, 1966). It is the most frequently used species in the prepa-
ration of Malaysian traditional medicine, and is also used as spice,
food preservative and cooking ingredient. In a previous study,
curcumin, a principal in C. domestica, was found to suppress the
action of tumour promoters in vitro and in vivo (Nishino et al,
1990). Curcumin inhibited TPA-enhanced phospholipid metabo-
lism in cultured cells and was demonstrated to have anti-tumour-
promoting activity in mouse skin carcinogenesis induced by TPA,
however further experiments revealed that various kinds of anti-
tumour promoter agents are mixed in the C. domestica rhizome
(Nishino et al, 1990).
The chloroform extracts of Z.  cassumunar and  Z.  zerumbet
showed strong EA inhibitory activity, similar to C.  domestica,
showing that they possess active components as potent as C.
domestica.  Z.  cassumunar and  Z.  zerumbet are cultivated in
Malaysia for medicinal purposes and are found in the prescriptions
of various traditional medicines (Burkill, 1966).
Kaempferia galanga rhizome that exhibited partial EA
inhibitory activity is a favourite among the Malaysians who call it
chekur. It is cultivated and is used medicinally to treat children and
as a cooking ingredient (Burkill, 1966). In a previous study, the
extract of K. galanga rhizome showed inhibition on TPA-stimu-
lated phospholipid synthesis (Nishino et al, 1990).
Z. officinale is another widely used species of the Zingiberaceae
family. It is a common additive in a large number of compounded
foods and beverages because of its flavour and pungency. Z. offic-
inale and its red variety are common ingredients in the Malaysian
traditional medicine, but little has been studied on their anti-
tumour-promoting activity. In this study, both the ginger varieties
were found to demonstrate EA inhibitory activity. C. xanthorrhiza,
popularly found in traditional tonic preparation (Burkill, 1966),
also demonstrated EA inhibitory activity.
It is worthwhile to note that the seven ginger rhizobia found to
possess EBV-EA inhibitory activity in the present study are
common ingredients in food, tonics and traditional preparations
that have been consumed over the years, indicating that they are
probably free from toxicity and side-effects. The present results
that showed no cytotoxicity effect in Raji cells at concentrations
that completely inhibited EA activation support this assumption.
Table 3 Percentage killing of Raji cells (cytotoxicity assay)
Plant Extract
(vernacular name)
Extract concentration (mg ml–1)
20 40 80 160 320 640
Curcuma domestica Petroleum ether 0 0 0 90 97 100
(kunyit) Chloroform 0 0 0 0 0 0
Ethanol 0 0 0 0 0 0
Curcuma xanthorrhiza Chloroform 0 0 90 95 98 100
(temu lawak) Ethanol 0 0 0 0 90 100
Kaempferia galanga Ethanol 0 0 0 0 0 0
(chekur)
Zingiber cassumunar Petroleum ether 0 0 0 75 80 100
(bonglai) Chloroform 0 0 0 0 0 0
Ethanol 0 0 0 0 0 0
Zingiber officinale Petroleum ether 0 0 0 0 100 100
(halia) Chloroform 0 0 0 0 100 100
Ethanol 0 0 0 0 100 100
Zingiber officinale Petroleum ether 0 0 0 90 98 100
(red variety) Chloroform 0 0 0 0 95 100
(halia bara) Ethanol 0 0 0 0 0 100
Zingiber zerumbet Chloroform 0 0 0 0 90 100
(lempoyang) Ethanol 0 0 0 0 0 60
0, No cytotoxicity relative to controls. Data, expressed as percentage of killing, are mean values of duplicate experiments (s.d.<5%).Epidemiological studies have identified populations less prone to
cancer, suggesting that environmental factors including diet may
have an important contributory role (Doll, 1992; Watternberg,
1992; Ziegler et al, 1992; Rogers et al, 1993).
In cancer prevention, it would be effective to block the three
stages of carcinogenesis independently or concurrently. However,
it is worthwhile searching for effective anti-tumour promoters
because the promotion stage is known to need a long-term period
for completion and is the only process possessing reversibility
(Berenbelum, 1975). Pitot and Sirica (1980) showed evidence that
pure initiation caused irreversible change but not neoplasm unless
a promoter is applied. Thus, the crucial step in the development
of human cancer may be the second stage of carcinogenesis, i.e.
the tumour promotion stage and not the first initiation stage.
Epidemiological evidence argues strongly that tumour promotion
is a significant factor in the final development of cancer in humans
(Hammond, 1975).
At present, cancer patients treated with chemical chemopreven-
tive compounds, which effectively suppress the evolution of the
neoplastic process, are also exposed to the permissible risk of
toxicity from the chemopreventive agent that increases with the
dosage (Wattenberg, 1985). Findings in the present study,
however, showed that the ginger rhizobia extracts which showed
strong EBV-EA inhibitory activity did not cause any cytotoxicity
effect in Raji cells.
Populations with high risk of cancer could be encouraged to
take in their diets plants with anti-tumour-promoting principles.
Although such an approach may not totally eliminate the disease,
it could form one method of control. However, such methods have
not been previously assessed and the efficacy of appropriate diets
in control of cancer need to be investigated.
In the case of these ginger plants which have been studied,
further investigations are being carried out to isolate and identify
the active compounds in each and to demonstrate that they possess
strong anti-tumour promoter activity in in vivo experiments. The
detection and further analysis of these natural compounds could be
useful in the development of a formulation for the dietary control
of malignancies.
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